ClinicalTrials.gov
ClinicalTrials.gov Menu

Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00950248
Recruitment Status : Active, not recruiting
First Posted : July 31, 2009
Last Update Posted : May 8, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Neurological Disorders and Stroke (NINDS) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 30, 2018
  Estimated Study Completion Date : August 1, 2018
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):